1

Curriculum VitaeSteven R. Erickson

Office Address:The University of Michigan College of Pharmacy Ann Arbor, Michigan 48109-1065

Telephone (734) 763 4989Fax (734) 763 2022

E-mail serick@umich.edu

PRESENT POSITION AND DATE OF EMPLOYMENT:

University of Michigan College of PharmacyAssociate Professor with Tenure, September 2004 to presentAssistant Professor, January, 1995 to September 2004

EDUCATION:

Baccalaureate: Ferris State College, Big Rapids, MI; 1980

Doctor of Pharmacy: Wayne State University, Detroit, MI; 1984

Professional Enhancement: Summer Sessions 1991, 1992 and 1996, Clinical Epidemiology, School of Public Health, University of Michigan. Course work included Epidemiology of Aging, Clinical Research Design, Research Analysis, Clinical Epidemiology, Pharmacoepidemiology.

Summer Session 1995 Institute for Social Research, University of Michigan. Coursework included Questionnaire Design and Introduction to Survey Research.

Medical Expenditure Panel Survey training workshops, Agency for Healthcare Research and Quality, September and November 2004.

PHARMACY LICENSURE:

Michigan

PREVIOUS EMPLOYMENT:

Wayne State University, College of Pharmacy, Detroit, MI. August 1990 to December 1994. Assistant Professor (Clinical), Department of Pharmacy Practice.

2

Ambulatory care practitioner in the Detroit Medical Center, University Health Center general medicine clinic as well as the Harper Geriatric clinic.

Professional Consultation, Nursing Home Consultant, Oakwood Hospital and TeleRex Pharmacy 1990 - 1994.

Consultant to four long-term care facilities in the Detroit Metropolitan area. Provided chart review, staff development, and pharmacokinetic dosing services. Acted as representative of the pharmacy at quality assurance meetings.

St. Mary Hospital, Livonia, MI. May 1988 to August 1990. Clinical Coordinator

Developed new clinical programs which included aminoglycoside and vancomycin pharmacokinetic dosing service, renal dosing service, and antimicrobial stewardship team. Coordinated and led staff development to support initial training and periodic updating of clinical skills to support clinical pharmacy programs. Member of the Pharmacy and Therapeutics Committee. Daily pharmacy rounds in the medical ICU and cardiac ICU.

Heritage Hospital, Taylor, MI. September 1987 to May 1988. Clinical Coordinator

Developed new clinical programs which included aminoglycoside and vancomycin pharmacokinetic dosing service and antimicrobial stewardship team. Coordinated and led staff development to support initial training and periodic updating of clinical skills to support clinical pharmacy programs. Member of the Pharmacy and Therapeutics Committee.

Sinai Hospital of Detroit, Detroit, MI. September 1985 to August 1987. Section Head, Cardiology and Rehabilitation Medicine, Department of Pharmacy.

Responsibilities included direct supervision of a team of 6 pharmacists and 4 technicians; staff development to support clinical programs for patient care areas covered by my team; quality assurance monitoring and assessment of clinical activities of pharmacists; quality assurance assessment of prescribing for targeted medications in the cardiac intensive care unit and step-down units; daily pharmacy rounds in the cardiac ICU and step-down unit; development and assessment of the patient self-medication training program for the in-patient physical rehabilitation unit.

Wm. Beaumont Hospital - Troy, MI. March 1984 to September 1985. Clinical Pharmacy Coordinator, Department of Pharmacy.

Expansion of existing clinical programs which included aminoglycoside and vancomycin pharmacokinetic dosing service. Coordinated and led staff development to support initial training and periodic updating of clinical skills to support clinical pharmacy programs. Initiated quality assurance program to assess renal dosing of medications for in-patients. Developed the metered dose inhaler technique education program for hospitalized patients, in which all patients admitted who received an inhaler underwent assessment and education related to inhaler technique.

Meijer Thrifty Acres, Kalamazoo, MI. May 1980 to September 1982. Staff pharmacist

3

PROFESSIONAL AND RESEARCH ORGANIZATION MEMBERSHIPS:

International Society for Quality of Life Research (member 1996 to present)

International Society for Pharmacoeconomics and Outcomes Research (member 1997 to present)

American Association of Colleges of Pharmacy (member 1990 to present)

Academy for Managed Care Pharmacy (member 2010 to present)Faculty advisor, University of Michigan student chapter

Michigan Pharmacists Association (member 1980 to present)

HONORS/AWARDS

Rho Chi Pharmacy Honor Society (WSU 1983)Sandoz Research Award (WSU Pharm.D. program, 1984)Kappa Psi Scholastic Award (FSC Baccalaureate program 1980).

University of Michigan College of Pharmacy Student Appreciation Award P-3 class 2002-2003P-3 class 2005-2006P-1 class 2005-2006P-1 class 2007-2008P-3 class 2011-2012

TEACHING

Primary courses at the University of Michigan

1. Ambulatory Care Clerkship - Adult Internal Medicine, preceptor (1995-2011)2. Pathophysiology and Therapeutics for Primary Care Nursing, P621. Subjects included

hypertension, cardiovascular disease. (1995- 2011)3. Pathophysiology and Therapeutics. Subjects included cardiovascular disease, hypertension,

male health (1995-2005)4. Pharmaceutical Care Labs, Coordinator,

Pharmaceutical Care II, Dispensing lab, P352 (2008-2011)Pharmaceutical Care IV, P551 (2008-2011)

5. University of Michigan Health System Department of Pharmacy general practice pharmacy resident, preceptor (1995-2005)

6. Pharm.D. Investigations (1995-present)7. Pharm.D. Seminar advisor (1995-present)8. Patient-Reported Outcomes, P724: graduate level course to Social and Administrative

Sciences graduate students (2008 to present)9. Pharmacy and the US Health System, P420, Course Coordinator and lecturer (2011-present)10. Pharmacy Law and Ethics P520, P530, Course Coordinator and lecturer (2012-present)

4

11. Community Pharmacy P404, lecture and lab, Course Coordinator (2008-2009); Pharmacy law lectures in community pharmacy (2010- present)

Post-PharmD Health Services Research/Outcomes Research Fellowship, University of Michigan – Co-Preceptor

1. Jeffrey J. Ellis 2003-20042. Brian DeSmet 2005-2006

University of Michigan Multidisciplinary Clinical Researchers in Training (MCRiT) Summer Practicum - Research mentor – College of Pharmacy Students

1. Alexandra Tungal2. Christopher Truong3. Matthew Lau4. Jade Lee

Graduate Students – University of Michigan, Social and Administrative Sciences Graduate Program

1. Dissertation Committees

Robert Christen, University of Michigan College of PharmacyPhD dissertation committee member , 1997

Janice Schreiffer, University of Michigan School of Public HealthScD dissertation committee member, 2004

Uscha Mallya, University of Michigan College of PharmacyPhD dissertation committee member, 2006

Anagha Nadkarni, University of Michigan College of Pharmacy, PhD dissertation committee member , 2008

Chung-Hsuen Wu, University of Michigan College of Pharmacy, PhD dissertation committee member, 2010

Huang-Tz Ou, University of Michigan College of Pharmacy, PhD dissertation committee member, 2010

Hsien-Chang Lin, University of Michigan School of Public Health/College of Pharmacy, PhD dissertation committee member, 2010

Jongwha Chang, University of Michigan College of Pharmacy, PhD dissertation committee member, 2012

2. Prelim Research Proposal Mentor

5

Justin Gatwood, 2012Ala Iaconni, 2012Erin Thatcher, 2012

Courses/lectures taught at Wayne State University (1990 to 1994)

1. Nonprescription Medications2. Techniques in Patient Counseling and Education.3. Pathophysiology and Therapeutics I - Rheumatology, Geriatrics, Hypertension and

Hyperlipidemia4. Critical Analysis of Drug Related Problems 5. Geriatric elective - course co-coordinator6. Doctor of Pharmacy clerkship/Ambulatory care 7. Doctor of Pharmacy clerkship/Geriatrics (1 year)8. Ambulatory Care clinical rotation for pharmacy residents Detroit Receiving Hospital, 1990-

95.9. Therapeutics - WSU School of Nursing - lecturer10. Ambulatory Care Fellowship - co-preceptor, 1994-95.

Courses/lectures taught at Madonna University (2000, 2001 and 2006)

1. Advanced Pharmacology (NUR 535)- topics include general principles of pharmacokinetics, hyperlipidemia, ischemic heart disease, hypertension, congestive heart failure, asthma, chronic obstructive pulmonary disease, and allergic rhinitis.

RESEARCH

Funded Projects

H2-antagonist DUE for Bluecare Network. Co-investigator. Merck-Astra. $25,000, 1991.

Impact of pharmaceutical care on the outcomes of patients with asthma. Co-investigator. American Society for Hospital Pharmacists. $5000, 1992.

Impact of comprehensive pharmacy services on a long term care institution. Co-investigator. Maria Health Care Center, $3000; Wayne State University Small Grants, $600. 1992.

Impact of doctor of pharmacy student interventions on a managed care program. Principal investigator. Rhone-Poulan Rorer. $2000, 1992.

A comparison of the availability and utilization of pharmacy services by elderly living in urban and suburban areas. Principal investigator. American Association of Colleges of Pharmacy - Parke-Davis ElderCare. $5000, 1992.

Survey of pharmacists attitudes towards patient counseling education. Co-investigator. Glaxo, $5000. 1993.

6

Impact of pharmaceutical care on the outcomes of hypertensive therapy in an internal medicine clinic. Principal investigator. Upjohn, $9350. 1993.

Impact of pharmaceutical care on the outcomes of patients with type II diabetes. Co-investigator. Upjohn, $9350. 1993.

Medication use by tenants of senior apartment complexes. Principal investigator, Restoration Towers, Detroit, Mi. $2000; Wayne State University Internal Small Grants, $600. 1993.

Evaluation of the Pharmacotherapy Management Model in Asthmatic Patients: A Pilot Study. Co-investigator. Medtronic. $17,000. 1995.

Health resource utilization and outcomes in patients with asthma. Principal investigator. The Upjohn Research Endowment Fund for Pharmaceutical Research, University of Michigan College of Pharmacy. $25,000. 1996.

Use of the SF-36 to identify antihypertensive side effects. Principal investigator. The Clinical Research Resources Committee grant, University of Michigan College of Pharmacy. $14,489. 1996.

Effect of individualized medication compliance reminder messages on outcomes of patients with uncontrolled hypertension. Co-investigator. PolyPharm, Inc. $20,000, 1997.

Content and construct validation of the Metered-dose Inhaler Technique Questionnaire using the MDI-log as a gold standard. Principal investigator. University of Michigan, OVPR Discretionary Fund. $3845. 1998.

Assessment of Prescribing Lipid Lowering Agents in a Primary Care Clinic. Principal investigator. Parke Davis, $4000. 1999

Work outcomes and health-related quality of life in patients with anxiety disorders. Comparison of work performance questionnaires. Principal investigator. The Upjohn Research Endowment Fund for Pharmaceutical Research, University of Michigan College of Pharmacy. $19,087. 2001.

Health-related quality of life and perceived work performance of patients undergoing smoking cessation. Principal investigator. Clinical Research Resources Committee grant, University of Michigan College of Pharmacy. $6762. 2001.

Health-related quality of life and work performance of patients after acute coronary syndrome. Principal investigator. Clinical Research Resources Committee grant, University of Michigan - College Of Pharmacy. $6700. 2002.

The patient’s role in medication safety. Co-investigator. Research Resources Committee, University of Michigan - College Of Pharmacy. $11,542. 2003.

7

Developing effective uses of hand-held video devices in classroom and field instruction. University of Michigan Whitaker Fund for the Improvement of Teaching. Principal Investigator. $10,000, 2006-2007.

Developing a comorbidity index for health-related quality of life studies. Agency for Health-Care Research and Quality, R03. 1 R03 HS017461-01A1 $67,294. 2008-2009. Principal Investigator. 20% effort.

Chronic illness and medication therapy of committed exercisers: a comparison between United States Masters Swimmers and the general population (NHANES). $1500. 2011

Health literacy of caregivers of adults with developmental disabilities. University of Michigan MICHR Seed Grant $5000. 2012

Medication adherence to statins in the State of Michigan: spatial analysis. University of Michigan Cardiovascular Center Microgrant, $5000. 2013

Current research interests

Development and assessment of innovative pharmacy services to improve the outcomes of appropriate use of medications.

Assessment of medication use processes to ensure the safe and effective use of medications by people with intellectual and developmental disabilities.

Study of patient, disease, and treatment factors associated with health related quality of life, patient-perceived functional status, and measured functional status and performance.

Development and refinement of risk-adjustment models to improve prediction of health status, health care resource use, and mortality.

Study of the association between geographic, neighborhood, and spatial factors with medication adherence and persistence.

PUBLICATIONS

Research

Mitala JJ, Erickson SR. Method for repetitive blood sampling in the dog: a modification. J Pharmacol Methods 1981;5:175-177.

Rybak MJ, Boike SC, Levine DP, Erickson SR. Clinical use and toxicity of high-dose tobramycin in patients with Pseudomonal endocarditis. J Antimicrob Chemother 1986;17:115-120.

Slaughter R, Thomson P, Erickson SR. Clinical interventions by doctor of pharmacy students. Ann of Pharmacother 1994;28:665-670.

8

Erickson SR, Hirshorn B. Community pharmacy services in urban and suburban areas, with emphasis on those for older people. J Pharm Technol 1995;12:45-51.

Erickson SR, Halapy H, Slaughter R. Pharmacist ability to influence the outcomes of antihypertensive drug therapy. Pharmacotherapy, 1997;17:9-18.

Bleske BE, Cornish LA, Erickson SR, Nicklas JM. Evaluation of ACE Inhibitor therapy for congestive heart failure in an outpatient setting. J Pharm Technol 1998;14:7-11.

Erickson SR, Kirking DM, Sandusky M. Michigan Medicaid patients’ perceptions of medication counseling as required by OBRA 90. J Am Pharm Assoc 1998;38:333-338.

Erickson SR, Horton A, Kirking DM. Assessing metered dose inhaler technique: comparison of observation versus patient self-report. J Asthma 1998;35:575-583.

Erickson SR, Ascione FJ, Kirking DM, Johnson CE. Use of a paging system to improve medication self-management in patients with asthma. J Am Pharm Assoc 1998;38:767-769.

Erickson SR, Landino H, Zarowitz B, Kirking DM. Pharmacists’ understanding of patient education on metered-dose inhaler technique. Ann Pharmacother 2000;34:1249-1256.

Erickson SR, Coombs JH, Kirking DM, Azimi AR. Compliance from self-reported versus pharmacy claims data with metered-dose inhalers. Ann Pharmacother 2001;35:997-1003.

Erickson SR, Williams BC, Gruppen LD. Perceived symptoms and health-related quality of life reported by uncomplicated hypertensive patients compared to normal controls. J Human Hyperten 2001;15:539-548.

Mani O, Mehta RH, Tsai T, Van Riper S, Cooper J, Kline-Rogers E, Nolan E, Kearly G, Erickson SR, Eagle KA. Performance reports to individual providers in the care of acute coronary syndromes: insights into acceptability and formatting from a university health system. The Joint Commission Journal on Quality Improvement 2002;28:220-232.

Erickson SR, Kirking DM. A cross-sectional analysis of work-related outcomes in adults with asthma. Ann Allergy Immunol 2002;88:292-300.

Erickson SR, Munzenberger PJ, Venuya R, Hurwitz M, Plante M. Effects of socioeconomic variables on the health related quality of life of pediatric patients with asthma. J Asthma 2002;39;107-117.

Erickson SR, Christian RD, Kirking DM, Halman LJ. Relationship between patient and disease characteristics, and health-related quality of life in adults with asthma. Respir Med 2002;96:450-460.

McBurney CR, Eagle KA, Kline-Rogers EM, Cooper JV, Mani OCM, Smith DE, Erickson SR. Health-related quality of life in patients 7 months after a myocardial infarction: factors affecting the Short Form-12. Pharmacotherapy 2002;22:1616-1622.

9

Erickson SR, Chang A, Johnson CE, Gruppen LD. Lecture versus web tutorial for pharmacy students’ learning of MDI technique. Ann Pharmacother 2003;37:500-5005.

Lee S, Kirking DM, Erickson SR. Methods of measuring of asthma severity and their influence on patient assignment. Ann Allergy Asthma Immunol 2003;91:449-454.

Erickson SR, Williams BC, Gruppen LD. Relationship between symptoms and health-related quality of life in treated hypertensive patients. Pharmacotherapy 2004;24:344-350.

Ellis JJ, Erickson SR, Stevenson JG, Bernstein SJ, Stiles RA, Fendrick AM. Sub-optimal statin adherence and discontinuation in primary and secondary prevention populations: Should we target patients with the most to gain? J Gen Intern Med 2004;19:638-645.

Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care 2004;42:649-652. Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EQ, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med 2004;117:73-81.

McBurney CR, Eagle KA, Kline-Rogers E, Cooper JV, Smith DE, Erickson SR. Work-related outcomes after a myocardial infarction. Pharmacotherapy 2004;24:1515-1523.

Erickson SR, Thomas LA, Blitz SG. Health-related quality of life and work-performance of patients making an attempt at smoking cessation. Ann Pharmacother 2004;38:1805-1810.

Erickson SR, Kirking DM. Variation in the distribution of patient-reported outcomes based on different definitions of defining asthma severity. Curr Med Res Opin 2004;20:1863-1872.

Erickson SR, Ascione FJ, Kirking DM. Utility of a medication management electronic device for hypertensive patients: A pilot study. J Am Pharm Assoc 2005;45:88-91.

Ellis JJ, Eagle KA, Kline-Rogers EM, Erickson SR. Depressive symptoms and treatment after acute coronary syndrome. Intern J Cardiol 2005;99:443-447.

Nau D, Erickson SR. Medication safety: patients’ experiences, beliefs and behaviors. J Am Pharm Assoc 2005;45:452-457.

Ellis JJ, Eagle KA, Kline-Rogers EM, Erickson SR. Perceived work performance in patients who experienced an acute coronary syndrome event. Cardiology 2005;104:120-126.

Ellis JJ, Eagle KA, Kline-Rogers E, Erickson SR. Validation of the EQ-5D in patients with acute coronary syndrome. Curr Med Res Opin 2005;21:1209-1216.

Sud A, Kline-Rogers EM, Fang J, Armstrong D, Rangarajan K, Otten R, Stafkey D, Eagle KA, Taylor S, Erickson SR. Adherence to medications in patients discharged with Acute Coronary Syndrome. Ann Pharmacother 2005;39:1792-1797.

Nau DP, Ellis JJ, Kline-Rogers EM, Mallya U, Eagle KA, Erickson SR. Gender and perceived severity of cardiac disease: evidence that women are “tougher”. Am J Med 2005; 118:1256-1261.

10

DeSmet B, Erickson SR, Kirking DM. Predictors of adherence to asthma controller medications. Ann Pharmacother 2006;40:414-420.

Stumpf JL, Skyles AJ, Alaniz C, Erickson SR. Knowledge of appropriate acetaminophen doses and potential toxicities in an adult clinic population. J Am Pharm Assoc 2007;47:35-41.

Navarre M, Patel H, Johnson CE, Durance A, McMorris M, Bria W, Erickson SR. Influence of an interactive computer-based inhaler technique tutorial on patient knowledge and inhaler technique. Ann Pharmacother 2007;41:216-221.

Khanderia U, Townsend KA, Erickson SR, Vlasnik J, Prager RL, Eagle KA. Medication adherence following coronary artery bypass graft surgery: assessment of beliefs and attitudes. Ann Pharmacother 2008;42:192-199.

Reaume KT, Erickson SR, Dorsch MP, Dunham NLM, Hiniker SM, Prabhakar N, Kline-Rogers EM, Eagle KA. Effects of the withdrawal of cerivastatin on statin persistence. Ann Pharmacother 2008;42:956-961.

Wu CH, Erickson SR, Kennedy J. Patient characteristics associated with the use of antidepressants among people diagnosed with DSM-IV mood disorders: results from the National Comorbidity Survey Replication (NCS-R) survey. Curr Med Res Opin 2009;25:471-482.

Erickson SR, Ellis JJ, Smith DE, Kline-Rogers E, Eagle KA. Satisfaction with current health status in patients with a history of acute coronary syndrome. Curr Med Res Opin 2009;25:683-689.

Erickson SR, Rangarajan K, Kline-Rogers EM, Smith DE, Eagle KA. Association between use of 4 recommended drug categories and patient perceptions of health status following an ACS event. J Manag Care Pharm 2009;15:533-542.

Erickson SR, Guthrie S, VanEtten-Lee M, Himle J, Hoffman J, Santos SF, Janeck AS, Zivin K, Abelson JL. Severity of anxiety and work-related outcomes of patients with anxiety disorders. Depression and Anxiety, 2009;26:1165-1171. DOI 10.1002/da.20624

Weder A, Erickson SR. Treatment of hypertenison for hospital in-patients. J Clin Hypertens 2010;12:29-33. doi:10.1111/j.1751-7176.2009.00196.x

Anagha Nadkarni A, Kucukarslan SN, Bagozzi RP, Yates JF, Erickson SR. A simple and promising tool to improve self-monitoring of blood glucose in patients with diabetes. Diabetes Research and Clinical Practice 2010;89:30-37. doi:10.1016/diabres.2010.03.011

Julian FS, Martin P, Erickson SR. Validation of the SPNS adherence tool in HIV/AIDS patients. Ann Pharmacother 2010;44:1003-1009. DOI 10.1345/aph.1M690.

Erickson SR, Eagle KA. Commentary on: Interventions to improve secondary prevention after stroke are needed: adherence to prescribed prevention drugs after stroke declines rapidly during the first 2 years after hospital discharge. Evidence-Based Medicine 2010;15:97-98. doi:10.1136/ebm1063.

11

Gatwood J, Erickson SR. Medication adherence: The search for interventions that work. Am J Manag Care 2010;16:925-926.

Nadkarni A, Kucukarslan SZ, Bagozzi RP, Yates JF, Erickson SR. Examing determinants of self managment behaviors in patients with diabetes: An application of the Theoretical Model of Effortful Decision Making and Enactment. Patient Educ Couns 2010, doi:10.1016/j.pec.2010.09.027

Mukherjee B, Ou H, Wai F, Erickson SR. A new comorbidity index: the health-related quality of life comorbidity index (HRQL-CI). J Clin Epid 2011;64:309-319.

Bleske BB, Erickson SR, Fahoum S, Devarakonda KR, Welage LS, Koudmani M, Pantham N, Edwin SB, Devarakonda S, Shea MJ, Martha S, Khalidi N. Cardiovascular risk among university students from developed and developing nations. The Open Cardiovascular Medicine Journal 2011;5:117-122.

Dorsch MP, Erickson SR, Bleske BE, Weder A. Improved nonfatal cardiovascular events with chlorthalidone compared to hydrochlorothiazide. Hypertension 2011;57:689-694.

Gatwood J, Tungol A, Truong C, Kucukarslan SN, Erickson SR. Prevalence and predictors of utilization of community pharmacy generic drug discount programs. J Manag Care Pharm 2011;17:1-7.

Hoang C, Kolenic G, Kline-Rogers E, Eagle KA, Erickson SR. Mapping medication taking behavior of patients discharged for the treatment of acute coronary syndrome. Pharmacotherapy 2011;31:927-933.

Ou HT, Erickson SR, Mukherjee B, Bagozzi R, Piette JD, Balkrishnan R. Comparative performance of comorbidity indices in discriminating health related behaviors and outcomes. Health Outcomes Research in Medicine 2011;2:e91-e104.

Lin HC, Erickson SR, Balkrishnan R. Antidepressant utilization, adherence, and health care spending in the United States: The case of MDD patients 2000-2007. Health Outcomes Research in Medicine 2011;2:e79-e89.

Wu CH, Erickson SR, Piette JD, Balkrishnan R. Mental health resource utilization and health care costs associated with race and comorbid anxiety among Medicaid enrollees with major depressive disorder. J Natl Med Assoc 2012;104:78-88.

Lin HC, Erickson SR, Balkrishnan R. Physician prescribing patterns of innovative antidepressants in the United States: The case of MDD patients 1993-2007. Int’l J Psychiatry in Medicine 2011;42:355-370.

Chisholm-Burns MA, Erickson SR, Spivey CA, Kaplan B. Employment and health-related quality of life among renal transplant recipients. Clin Transplant 2011 DOI:10.1111/j.1399-0012.2011.01541.x.

12

Chisholm-Burns MA, Erickson SR, Spivey CA, Kaplan B. Concurrent validity of the Kidney Transplant Questionnaire in renal transplant recipients. Patient Preference and Adherence 2011;5:517-522.

Eagle TF, Sheetz A, Gurm R, Woodward AC, Kline-Rogers E, Leibowitz R, DuRussel-Weston J, Palma-Davis L, Aaronson S, Fitzgerald CM, Mitchell LR, Rogers B, Bruenger P, Skala KA, Goldberg C, Jackson EA, Erickson SR, Eagle KA. Understanding childhood obesity in America: Linkages between household income, community resources, and children’s behavior. Am Heart J 2012;163:836-843.

Ou HT, Erickson SR, Mukherjee B, Bagozzi R, Piette JD, Balkrishnan R. Comparative performance of comorbidity indices in predicting healthcare related behaviors and outcomes among Medicaid enrollees with type-2 diabetes. Population Health Management 2012;15:220-229.

Wu C-H, Erickson SR, Piette JD, Balkrishnan R. The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder. Res Social Adm Pharm 2012;8:193-205.

Erickson SR, Guthrie S. Health status of USMS swimmers compared to a representative sample of the general population. International Journal of Aquatic Research and Education 2012;6:226-234.

Caruthers RL, Kempa M, Loo A, Gulbransen E, Kelly E, Erickson SR, Hirsch JC, Schumacher KR, Stringer KA. Demographic characteristics and estimated prevalence of Fontan-associated plastic bronchitis. Pediatr Cardiol 2012; DOI 10.1007/s00246-012-0430-5.

Wu C-H, Erickson SR. The association between asthma and absenteeism among working adults in the United States: Results from the 2008 Medical Expenditure Panel Survey. J Asthma 2012. DOI. 10.3109/02770903.2012.709292.

Hatcher E, VanWert E, Erickson SR. Potential impact of pharmacist interventions to reduce cost for Medicare Part D beneficiaries. J Pharm Practice 2012. DOI: 10.1177/0897190012465983.

Guthrie SK, Erickson SR, Lau MS. Comparison of the prevalence and treatment of hypertension in two populations in the United States: Masters swimmers versus the NHANES population. J Sports Scien 2013. http://dx.doi.org/ 10.1080/02640414.2012. 757346

Erickson SR, Cole E, Kline-Rogers E, Eagle KA. The addition of the Charlson Comorbidity Index to the GRACE Risk Prediction Index improves prediction of outcomes in Acute Coronary Syndrome. In press, 2013, Population Health Management.

Chang J, Freed GL, Prosser LA, Patel I, Erickson SR, Bagozzi RP, Balkrishnan R. Comparisons of health care utilization outcomes in children with asthma enrolled in private insurance plans versus Medicaid. In press, 2013, J Pediatric Health Care.

13

Chang J, Freed GL, Prosser LA, Patel I, Erickson SR, Bagozzi RP, Balkrishnan R. Associations between physician financial incentives and the prescribing of anti-asthmatic medications in children in US outpatient settings. J Child Health Care 2013 DOI: 10.1177/1367493512456110

Letter and Abstracts

Erickson SR. P&T Committee subcommittees (letter). Hosp Formul 1990;25:999,1002.

Erickson SR, Slaughter R, Thomson P. Clinical interventions provided by Pharm.D. students on an ambulatory care clerkship. Abstract. Pharmacotherapy 1992;12:507.

Erickson SR, Halapy H, Slaughter R. Pharmacists’ ability to influence outcomes of antihypertensive pharmacotherapy. Abstract. Pharmacotherapy 1995;15:399.

Erickson SR, Munzenberger PJ, Kirking DM, Plant M, Johnson CE, Hurwitz M, Vinuya R. Influence of sociodemographics on the health-related quality of life of pediatric patients with asthma. Abstract. Pharmacotherapy 1997;17:1105.

Erickson SR, Kirking DM. Comparison of the SF-12 and SF-36 summary scores in a managed care asthmatic population. Abstract. Pharmacotherapy 1997;17:1106.

Erickson SR, Williams BC, Gruppen LD. Comparison of health-related quality of life and symptoms of hypertensive patients with normal controls. Abstract. Pharmacotherapy 1997;17:1107.

Erickson SR, Kirking DM. Asthma and work outcomes. Abstract. Pharmacotherapy 1998;18:1163.

Lee DC, Belden TL, Erickson SR, Samuels KM, Ascione FJ, Welage LS. Evaluation of pharmacy students’ and residents’ clinical interventions on a critical care rotation. Abstract. Pharmacotherapy 1999;19:512.

Erickson, SR, Kirking DM. Longitudinal assessment of asthma and work outcomes. Abstract. Value in Health 1999;2:365.

Erickson SR, McBurney CR, Kline-Rogers EM, Cooper JV, Mani OCM, Eagle KA. Work-related outcomes of patients six months after myocardial infarction. Abstract. Value in Health 2001;4:57-58.

McBurney CR, Erickson SR, Kline-Rogers EM, Cooper JV, Mani OCM, Eagle KA. Assessing quality of life in patients six months after a myocardial infarction using the SF-12. Abstract. Value in Health 2001;4:96-97.

Erickson SR, Kirking DM, Bria WF. Relationship between different measures of asthma severity: patient-perceived, symptom derived, and FEV1 determined severity measures. Abstract. Value in Health, 2002;134.

McBurney CR, Erickson SR, Kline-Rogers EM, Smith DE, Eagle KA. More medications and disease states were related to an increase in medication adherence among patients after a myocardial infarction. Abstract. Value in Health 2002;5:176-177.

14

Ellis JJ, Erickson SR, Stevenson JG, Bernstein SJ, Stiles RA, Fendrick AM. Sub-optimal statin compliance in primary and secondary prevention populations: should we target patients with the most to gain? Abstract. Value in Health. 2002;5:125-126.

Ellis JJ, Erickson SR, Kline-Rogers EM, Smith DE, Cooper JV, Eagle KA. Predictive models of health related quality of life utilizing patient reported outcomes data from a population with a history of acute coronary syndrome. Abstract. Value in Health 2003;6:326.

Stafkey DR, Erickson SR, Kline-Rogers EM, Smith DE, Cooper JV, Chang A, Eagle KA. Relationship between patient beliefs about medication and self-reported medication adherence six months after discharge for acute coronary syndromes. Abstract. Value in Health 2003;6:312.

Ellis JJ, Erickson SR, Kline-Rogers EM, Smith DE, Cooper JV, Eagle KA. Description and predictive modeling of perceived work performance in an acute coronary syndrome population. Abstract. Value in Health 2003;6:325-326.

Ellis JJ, Kirking DM, Erickson SR. Non-procurement of prescription medications due to cost in Medicare beneficiaries: results from the Health and Retirement Study. Abstract. Value in Health 2003;6:190-191.

Garber M, Nau DP, Erickson SR. The congruence of self-report with other measures of medication adherence: a summary of the literature. Abstract. Value in Health 2003;6:293-294.

Ellis JJ, Eagle KA, Kline-Rogers EM, Rogers B, Erickson SR. Validation of the EQ-5D questionnaire in patients with a history of acute coronary syndrome. Abstract. Value in Health 2004;7:328-329.

Ellis JJ, Eagle KA, Kline-Rogers EM, Rogers B, Erickson SR. Health related quality of life in an acute coronary syndrome population is affected by depression treatment adequacy. Abstract. Value in Health 2004;7:329-330.

Erickson SR, Thomas LA, Blitz SG. Health-related quality of life of patients making an attempt at smoking cessation. Abstract, Value in Health, May;2004;3:329.

DeSmet BD, Erickson SR, Kirking DM. Predictors of self-reported adherence in patients with asthma. Poster presentation, International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting, Arlington, May 2004. Value in Health 2004;3:134.

DeSmet BD, Erickson SR. Influence of various health status measures on total expenditures in the MEPS dataset. Value in Health, May 2005.

Erickson SR, Ellis JJ, Kline-Rogers E, Eagle K. Satisfaction with current health state in patients with a history of acute coronary syndrome. Circulation May 24, 2005 on-line.

Kaakeh R, Erickson SR. Assessment of the association between summary symptom measures and health status of patients with ischemic heart disease. Abstract. Value in Health 2010;13:A362.

15

Ou HT, Balkrishnan R, Erickson SR, Bagozzi RP, Mukherjee B, Piette JD. Performance of comorbidity measures in health care related behaviors and outcomes in type 2 diabetes. Abstact, Value in Health 2010:13:A284.

Review Papers (Peer-Reviewed )

Erickson SR, Wenzloff N. Current concepts in the treatment of urinary tract infections. Pharm Times 1985;51:106-117.

Erickson SR, Lewis NW. Cost considerations in the treatment of hypertension. American Druggist 1992;November:89-104.

Erickson SR. Quality of life issues for the pharmacist. J Mich Pharm 1992;30:364-69.

Continuing Education Papers

Erickson SR. Understanding and treating erectile dysfunction. Power-Pak Communications. 1998

Erickson SR. Medication-induced constipation. Power-Pak Communications. 1998.

Erickson SR. Overactive Bladder: A treatable condition. Power-Pak Communications 1999.

Erickson SR. COX-2 Inhibitors. Power-Pak Communications. 1999.

Erickson SR. Medication compliance and respiratory disease. Power-Pak Communications. 2000.

Erickson SR. Update on the treatment of overactive bladder. Power-Pak Communications. 2001.

Blaiss MS, Boone R, Erickson SR. Updating the evidence of allergic rhinitis management. First Report, Managed Care First Report. June 2008

Case Reports

Erickson SR, Yousuf MJ. Hypotension and bradycardia possibly associated with intraocular acetylcholine. DICP Ann Pharmacother 1991;25:1178-1181.

Book Chapters

Lewis NJW, Erickson SR. Pharmacists’ performance in drug product selection and therapeutic interchange. In: Social and behavioral aspects of pharmaceutical care. Smith M, Wertheimer A, eds. Hawthorn Press, 1996.

Erickson SR, Bostwick JR, Guthrie SK. Chapter 15. Psychological symptoms associated with cardiovascular drugs; Cardiac symptoms from psychiatric drugs; drug interactions. In: Psychiatry and heart disease. Riba M, Wulsin L, Rubenfire M, eds. Wiley-Blackwell, 2012.

16

PROFESSIONAL PRESENTATIONS

Research Presentations

Erickson SR, Cole E, Kline Rogers E, Eagle KA. GRACE risk prediction index, Charlson Comorbidity Index, or both, to predict outcomes associated with acute coronary syndrome. Podium Presentation, International Society for Pharmacoeconomics and Outcomes Research Annual International Meeting, Washington DC , June 2, 2012,

Gatwood J, Erickson SR. Trends in and predictors of discount generic medication program utilization. Poster. International Society for Pharmacoeconomics and Outcomes Research Annual International Meeting,. Maryland, MD. May 23, 2011

Chisholm-Burns MA, Erickson S, Spivey C. Concurrent validity evaluation of three quality of life instruments in a female renal transplant population. Presented at the 4th World Congress on Women’s Mental Health, Madrid, Spain, March 2011.

Chisholm-Burns MA, Spivey C, Erickson S. Employment and health-related quality of life among female renal transplant recipients. Presented at the 4th World Congress on Women’s Mental Health, Madrid, Spain, March 2011.

Chisholm-Burns MA, Erickson S, Spivey C.  Concurrent validity evaluation of three quality of life instruments in a renal transplant population. Presented at the 2011 World Congress of Nephrology, Vancouver, Canada, April 2011.

Chisholm-Burns MA, Erickson S, Spivey CA. Employment and health-related quality of life among renal transplant recipients. American Journal of Transplantation 2011;11(s2):365 [Abstract 1140]. Presented at the American Transplant Congress, Philadelphia, Pennsylvania, May 1, 2011.

Truong CQ, Erickson SR. Utilization of the $4 Generic Medicaion Plans by Patients From a General Medicine Clinic. Poster. American Pharmacists Association Annual Meeting, Seattle, WA. March 25, 2011.

Tungul A, Erickson SR, Kucukarsian S. Sources of medication in a general medicine population. Influence of the $4 generic programs. International Society for Pharmacoeconomics and Outcomes Research Annual Meeting, Atlanta, GE, May 15, 2010.

Dorsch MP, Erickson SR, Bleske BE, Weder A. Improved nonfatal cardiovascular events with chlorthalidone compared to hydrochlorothiazide; American Society of Hypertension 2010 Scientific Meeting; New York, NY. Abstract OR-8. May 2, 2010.

Erickson SR, Mukherjee B, Ou HT, Wang F. A new comorbidity index for studies of health-related quality of life. Poster presentation, International Society for Quality of Life Research, New Orleans LA, October 2010.

17

Wu CH, Erickson SR. The effect of asthma on work-related outcomes. Poster, American Pharmacists Association, March 2009.

Tamhane UU, Geiger Z, Jackson EA, Erickson SR, Montgomery DG, Gourineni N, Hameed I, Veeranna V, Kline-Rogers E, Gurm HS, Eagle KA, Froehlich JB. The eligibility for polypill therapy and outcomes in patients with Acute Coronary Syndrome. Poster Presentation, American Heart Association Quality of Care and Outcomes Research Annual Meeting, Washington DC, April 2009.

Innes M, Erickson SR. Trends in chronic obstructive pulmonary disease pharmacotherapy in the US, 1996-2005. Student poster presentation, American Society for Health-System Pharmacists, December 2008.

Erickson SR, Guthrie S, Abelson J. Health status and work-related outcomes of patients with anxiety disorders and depression. Poster presentation, International Society for Pharmacoeconomics and Outcomes Research, Toronto, CAN, May, 2008.

Khan S, Montgomery D, Erickson SR, Kline-Rogers E. Gender differences in medication adherence among discharged diabetic patients following episodes of acute coronary syndromes. Student Poster, UROP, University of Michigan, April 2008.

Wu CH, Erickson SR. Patient characteristics associated with medication use among people diagnosed with DSM-IV mood disorders: results from the National Comorbidity Survey Replication (NCS-R). Poster, American Pharmacists Association, March 2008.

Seif M, Zou N, Guthrie S, Erickson SR. Cardiovascular medication prescribing for committed exercisers: Survey of Michigan Master Swimmers’ Chronic Illnesses and Treatments. Student Poster, American Society for Health-System Pharmacists Midyear Meeting, December, 2007.

Yakkundki V, Erickson SR. Comparing the health outcomes of older workers versus older non-workers using the Medical Expenditures Panel Survey (MEPS) database. Student Poster, American Society for Health-System Pharmacists Midyear meeting, December, 2006.

Obianu U, Erickson SR. Work-related outcomes of adults with asthma in the United States. Student Poster, American Society for Health-System Pharmacists Midyear meeting, December, 2006. Mattei N, Erickson SR. Work-related outcomes of patients with anxiety disorders in the United States. Student Poster, American Society for Health-System Pharmacists Midyear meeting, December, 2006.

Rahnama-Moghadam S, Erickson SR, Henke P, Upchurch GR, Froehlich JB. Functional status in peripheral artery disease is predicted by both abnormal and low-normal ankle-brachial index: the National Health and Nutrition Examination Survey (NHANES). Poster presentation at the American College of Cardiology, New Orleans, March 2007.

Rangarajan K, Kline-Rogers E, Eagle KA, Smith D, Rogers A, Ng G, Valassis D, Erickson SR. Influence of repeated cardiac-related interventions on the persistence to evidence-based medications 8 months after acute coronary syndrome Poster presentation, American Heart Association 7th

18

Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Washington DC, May 8 2006.

Rangarajan K, Kline-Rogers E, Eagle KA, Smith D, Rogers A, Ng G, Valassis D, Erickson SR. Impact of combination evidence-based medical therapy on health status of patients with a recent history of acute coronary syndromes. Poster presentation, American Heart Association 7th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Washington DC, May 8 2006.

May N, Patel A, Kline-Rogers E, Fazel R, Fang J, Eagle KA, Erickson SR. Persistence to evidence-based medicines in patients with acute coronary syndromes before and after initiation of the Guidelines Applied in Practice program. Poster presentation, American Heart Association 7th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Washington DC, May 8 2006.

Galbraith EM, Erickson SR, Kline-Rogers E, Eagle KA, Sud A, Resin Y, Saab F, May N, Patel A. Medication taking behavior after acute coronary syndrome. Poster presentation, American Heart Association 7th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Washington DC, May 8 2006.

Patel A, Kline-Rogers E, May N, Fang J, Rangarjan K, Saab F, Resin Y, Erickson SR. Evidence-based medicine compliance in the very old. Poster presentation, American Heart Association 7th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Washington DC, May 8 2006.

Dombkowski KJ, Lakhani I, Erickson SR, Lewis TC. Asthma emergency department and controller medication utilization among frequent users of short-acting beta agonists. Poster presentation by K Dombkowski at the Pediatric Academic Society Annual Meeting, San Francisco, May 1, 2006.

Fazel R, Mukherjee D, Saab F, Kline-Rogers E, May NK, Fang J, Rogers B, Erickson SR, Eagle KA. Improved prescription of evidence-based medications and maintenance of high adherence to these medications in acute coronary syndrome patients after implementation of guidelines applied in practice. American College of Cardiology, Chicago, March 2006.

Erickson SR, Abelson JL, VanEtten-Lee M, Himle J, Hoffman J, Guthrie S, Janeck A. Effect of severity of anxiety on work performance and health-related quality of life. Poster Presentation, Anxiety Disorders Association of America, Miami, March 2006.

Patel H, Navarre M, Johnson CE, Erickson SR. Influence of an interactive computer-based inhaler technique tutorial on patient knowledge and inhaler technique. Student poster, American Society for Health-System Pharmacists Midyear meeting, December, 2005.

Nicasio A, Erickson SR. Bosentan treatment in patients with pulmonary arterial hypertension: reasons for discontinuation. Student Poster, American Society for Health-System Pharmacists Midyear meeting, December, 2005.

Erickson SR, Ellis JJ, Kline-Rogers E, Eagle K. Satisfaction with current health state in patients with a history of acute coronary syndrome. American Heart Association 6th Scientific Forum on Quality

19

of Care and Outcomes Research in Cardiovascular Disease and Stroke, Washington DC, May 15 2005.

DeSmet B, Erickson SR. Influence of various health status measures on total expenditures in the MEPS dataset. International Society for Pharmacoeconomics and Outcomes Research meeting, Washington DC, May 2005.

Hoffman J, Erickson SR, VanEtten-Lee M, Abelson JL, Himle J, Guthrie S. The nature and extent of impairment in work functioning within the anxiety disorders. Anxiety Disorders Association of American Conference, Seattle WA, April 2005.

Erickson SR, Thomas LA, Blitz SG. Health-related quality of life of patients making an attempt at smoking cessation. Poster presentation, International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting, Arlington, May 2004.

DeSmet BD, Erickson SR, Kirking DM. Predictors of self-reported adherence in patients with asthma. Poster presentation, International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting, Arlington, May 2004.

Ellis JJ, Eagle KA, Kline-Rogers E, Rogers BC, Erickson SR. Validation of the EQ-5D questionnaire in patients with a history of acute coronary syndrome. Poster presentation, International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting, Arlington, May 2004.

Ellis JJ, Eagle KA, Kline-Rogers E, Rogers BC, Erickson SR. Health-related quality of life in an acute coronary syndrome population is affected by depression treatment adequacy. Poster presentation, International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting, Arlington, May 2004.

Kline-Rogers E, Sud A, Armstrong D, Stafkey D, Smith DE, Eagle KA, Erickson SR. Relationship between patient beliefs about medication and self-reported medication adherence six months after discharge for acute coronary syndromes. Poster presentation by E. Kline-Rogers, 2nd Scientific Conference on Compliance in Healthcare and Research, American Heart Association, Washington DC, May, 2004.

Durance A, Bria W, McMorris M, Ojo T, Sanders G, Gray J, Johnson CE, Erickson SR. Influence of an interactive computer-based inhaler technique tutorial on patient knowledge and inhaler technique. Poster presented by A. Durance, American Thoracic Society International Conference, May 2004.

Sud A, Fang J, Kline-Rogers E, Erickson SR, Armstrong D, Rangarajan K, Otten R, Eagle K. Adherence to cardiac medications inpatients discharged with acute coronary syndromes. American College of Cardiology, March, 2004.

Nau D, Erickson SR, Ellis JJ. Gender differences in the perceived severity of cardiac disease. Poster presentation by D. Nau, American College of Preventive Medicine, February, 2004.

20

Marasigan D, Erickson SR, Johnson CE, Gruppen LD. Influence of an interactive CD-based inhaler technique tutorial on patient knowledge and use of diskus inhalers. Student poster presentation, D Marasigan, American Society for Health-System Pharmacists Midyear meeting, December, 2003.

Loomis LA, Erickson SR, Taylor ST, Remington TL. Health literacy and self-efficacy in osteoporosis prevention. Student poster presentation, L Loomis, American Society for Health-System Pharmacists Midyear meeting, December, 2003.

Skyles A, Stumpf J, Alaniz C, Erickson SR. Knowledge of appropriate acetaminophen doses and potential toxicities in an adult clinic population. Student poster presentation, A. Skyles, American Society for Health-System Pharmacists Midyear meeting, December, 2003.

Ellis JJ, Erickson SR, Kline-Rogers EM, Smith DE, Cooper JV, Eagle KA. Description and predictive modeling of perceived work performance in patients with a history of acute coronary syndrome. Poster presentation, Jeff Ellis, International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting, Arlington, May 2003.

Ellis JJ, Erickson SR, Kline-Rogers EM, Smith DE, Cooper JV, Eagle KA. Description and predictive modeling of health-related quality of life in patients with a history of acute coronary syndrome. Poster presentation, Jeff Ellis, International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting, Arlington, May 2003.

Stafkey D, Erickson SR, Kline-Rogers EM, Smith DE, Cooper JV, Eagle KA. Relationship between patient beliefs about medication and self-reported medication adherence six months after discharge for acute coronary syndromes. Poster presentation, Dana Stafkey, International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting, Arlington, May 2003.

Ellis JJ, Erickson SR, Kirking DM. Non-procurement of prescription medications due to cost in Medicare beneficiaries: Results from the Health and Retirement Study. Podium presentation by Jeff Ellis, International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting, Arlington, May 2003

Garber MC, Nau DP, Erickson SR. The congruence of self-report with other measures of medication adherence: A summary of the literature. Poster presentation, M. Garber, International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting, Arlington, May 2003.

Erickson SR, Ellis JJ, Kirking DM. The health-related quality of life of adults with asthma. Does definition of degree of asthma control make a difference? Poster presentation, Jeff Ellis, ASHP Clinical Midyear Meeting, December 2002.

Erickson SR, Kirking DM, Bria WF. Relationship between different measures of asthma severity: patient-perceived, symptom derived, and FEV1 Determined. Podium presentation, International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting, Arlington, May 2002.

McBurney CR, Erickson SR, Kline-Rogers EM, Cooper JV, Mani OCM, Eagle KA. Medication compliance six months after a myocardial infarction. International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting, Arlington, May 2002.

21

Ellis JJ, Erickson SR, Stevenson J, Stiles R, Bernstein S, Fendrick AM. Sub-optimal statin compliance in primary and secondary prevention populations: should we target patients with the most to gain? International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting, Arlington, May 2002.

Erickson SR, Kirking DK, Leidy NK. The effect of asthma severity on health-related quality of life and work performance: Does the definition of severity make a difference? Podium presentation, International Society for Quality of Life Research. Amsterdam, Netherlands, November 2001.

Erickson SR, Williams BC, Gruppen LD. Relationship between symptoms and SF-36 PCS and MCS scores in treated hypertensive patients. Poster presentation, International Society for Quality of Life Research. Amsterdam, Netherlands, November 2001.

Kline-Rogers EM, McBurney CR, Warber SL, Erickson SR, Almanaseer Y, Eagle KA. Complementary and alternative medicine use among acute coronary syndrome patients. Poster presentation, American Heart Association Scientific Meeting, Anaheim, California, November 2001.

Kline-Rogers EM, McBurney CR, Cooper JV, Erickson SR, Almanaseer Y, Eagle KA. Compliance with medication and behavioral therapies 6 months after hospital discharge in patients with acute coronary syndromes. Poster presentation, American Heart Association Scientific Meeting, Anaheim, California, November 2001.

McBurney CR, Erickson SR, Kline-Rogers EM, Cooper JV, Mani OCM, Eagle KA. Assessing quality of life in patients six months after a myocardial infarction using the Short Form 12. Poster presentation, International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting, Arlington, May 2001.

Erickson SR, McBurney CR, Kline-Rogers EM, Cooper JV, Man OCM, Eagle KA. Work-related outcomes of patients six months after myocardial infarction. Podium presentation, International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting, Arlington, May 2001.

Gulati A, Kline-Rogers EM, Mani OCM, Venkat D, Cooper JV, Kearly GE, Nolan E, Cody RJ, Erickson SR, Mehta RH, Eagle KA. Six-month compliance after hospital discharge in patients with acute coronary syndromes. Poster presentation, American College of Cardiology, Orlando, March 2001.

Lee S, Kirking D, Erickson S. Health resource utilization and associated costs by severity level for different measures of asthma severity. Podium presentation by S. Lee at the American Pharmaceutical Association, Pharmacy Research and Science Section, Clinical Sciences, Annual Meeting, San Francisco, March 2001.

Mehta T, Erickson SR, Blitz S, Thomas LA.The effects of smoking cessation on work outcomes and health-related quality of life. Poster presentation. American Society of Health-System Pharmacists, Midyear Clinical Meeting, Las Vegas, Nevada, December 2000.

Lee S, Kirking DM, Erickson SR. Assessing different measures to categorize asthma severity. Poster presentation. American Society of Health-system Pharmacists, Midyear Clinical Meeting, Las Vegas, Nevada, December 2000.

22

Erickson SR, Williams BC, Gruppen LD. SF-36 as a screening instrument to detect symptoms among hypertensive patients. Podium presentation. International Society for Quality of Life Research. Vancouver, British Columbia, November 2000.

Erickson SR, Ascione FA, Kirking DM. An individualized medication management system for hypertensive patients. Poster presentation, APhA Meeting, Washington DC, March 2000.

Silecchia S, Erickson SR. Assessment of physician prescribing of lipid lowering agents for patients with existing cardiovascular disease in a general medicine clinic. Poster presentation, ASHP Midyear Meeting, Atlanta, December 1999.

Erickson, SR, Kirking DM Longitudinal assessment of asthma and work outcomes. Podium presentation. ISPOR Second Annual European Conference, Edinburgh, Scotland, November 1999.

Lee DC, Belden TL, Erickson SR, Samules KM, Ascione FJ, Welage LS. Evaluation of pharmacy students’ and residents’ clinical interventions on a critical care rotation. Poster presentation ACCP/ESCP International Congress on Clinical Pharmacy meeting, April 1999. (Presented by Welage L).

Anderson J, Erickson SR. Construct validation of the Metered-dose Inhaler Technique Questionnaire. Poster presentation, ASHP Midyear Meeting, Las Vegas, December 1998.

Erickson SR. Asthma and work outcomes. Platform presentation, ACCP Annual Meeting, November 1998.

Christian R, Kirking DM, Erickson SR. Relationships between population characteristics, medication use behaviors and health resource use in patients with asthma. Platform presentation, APhA, March 1998.

Plante M, Munzenberger PJ, Erickson SR. Description of the health-related quality of life in an asthmatic pediatric population. Poster presentation, ASHP Midyear Meeting, Atlanta, December 1997.

Erickson SR. Comparison of the SF-12 and SF-36 summary scores in an adult asthmatic population. Poster presentation, ACCP Meeting, Phoenix, November 1997.

Erickson SR, Gruppen L, Williams BC. Comparison of symptoms and health-related quality of life in patients with hypertension compared with nonhypertensive patients. Poster presentation, ACCP Meeting, Phoenix, November 1997.

Erickson SR, Munzenberger PJ. Influence of sociodemographic variables on the health-related quality of life of pediatric patients with asthma. Podium presentation, ACCP Meeting Phoenix, November 1997.

Christian R, Kirking DM, Erickson SR. Relationships between patient characteristics and health-related quality of life in asthma patients. Podium presentation , APhA Meeting, Los Angeles, March 1997.

23

Erickson SR. Factors affecting metered-dose inhaler technique. Poster presentation, APhA Meeting, Los Angeles, March 1997.

Erickson SR, Kirking DM. Assessing metered-dose inhaler technique: a comparison of observation versus a patient questionnaire. Poster presentation, ASHP Midyear Meeting, New Orleans, December 1996.

Erickson SR, Halapy H, Slaughter R. Pharmacist ability to influence the outcomes of antihypertensive pharmacotherapy. Poster presentation, ACCP Annual Meeting, Washington DC, August 1995.

Erickson SR. Impact of pharmaceutical care and comprehensive education on outcomes of patients with asthma. Poster presentation, ASHP Annual Meeting, June 1995.

Erickson SR. Improving access to pharmaceutical care. Providence Hospital, Chronic Illness Awareness Coalition, Southfield, MI September, 1994.

Erickson SR. A comparison of the access and use of community pharmacy services by elderly living in urban versus suburban areas. Poster session, American Pharmaceutical Association, Seattle, WA. March 20, 1994.

Erickson SR. A comparison of the access and use of community pharmacy services by elderly living in urban versus suburban areas. Michigan Pharmacist Association Interim Meeting, Dearborn Hyatt, Dearborn, MI. February 1994,

Steinberger , Cardozza, Erickson. Interventions to reduce polypharmacy in the ambulatory elderly. Poster session, University of Michigan School of Nursing Management of Quality Meeting, November 1993.

Erickson SR, Slaughter R. Student interventions on an ambulatory care clerkship. ACCP Winter Meeting, poster session, Ft. Lauderdale, FL. February 1993.

Erickson SR, Kianni D, Keller K. Description of a restricted antibiotic monitoring program in a community hospital. Poster presentation. ASHP Clinical Midyear Meeting, Las Vegas, December, 1990.

Invited Educational Presentations

Working to ensure safe and effective use of medications by people with developmental disabilities. 29th Annual Developmental Disabilities Conference, Michigan State University, East Lansing, Michigan. April 24, 2013

Health literacy and its importance to safe medication administration. Educational lecture to direct support staffing agency employees and supervisors, Community Living Services, Wayne, Michigan. September 2012.

24

Pharmaceutical care and adults with developmental disability. Continuing Education Symposium, Michigan Pharmacist Association, Grand Rapids, Michigan. August 23 2011

So you want to survey your patients: An overview of survey methods to help you create and useful and successful survey. Michigan Pharmacists Association Annual Meeting, Detroit, Michigan. February 27, 2009.

Updating the evidence of allergic rhinitis management. Academy of Managed Care Pharmacy, San Francisco, May 2008.

Acetaminophen liver toxicity: Epidemiology, management, and need for education. Michigan Pharmacists Association, March 2008.

Medication adherence: What can you do to help your patients? Michigan Pharmacists Association, March 2008.

Introduction to health-related quality of life and patient-reported outcomes. A half-day short course at the International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting, Arlington, May 2005.

Introduction to health-related quality of life and patient-reported outcomes. A half-day short course at the International Society for Pharmacoeconomics and Outcomes Research, Annual Meeting, Arlington, May 2003.

Patterns of medication use for common chronic diseases. University of Michigan College of Pharmacy Annual Pharmacy Lectures, October 2001.

Quality of life issues in treating chronic heart failure and hyperlipidemia. University of Michigan College of Pharmacy Annual Spring Seminar, Ann Arbor, MI, April 2000

Pneumonias, COPD, and Asthma. Ferris State University, College of Pharmacy, Consultant Pharmacist Certificate Program. Grand Rapids, MI, November 1999

Update on the treatment of erectile dysfunction. St. Joseph Mercy Hospital, Pontiac, Michigan, Family Medicine Grand Round, October 1999.

Secondary agents for the treatment of arthritis. University of Michigan College of Pharmacy Tom D. Rowe Annual Pharmacy Lectures, October 1999.

Update on the treatment of erectile dysfunction. Monroe County Physicians Association, June 1999.

Pharmacotherapy and the older patient. University of Michigan College of Pharmacy Tom D. Rowe Annual Pharmacy Lectures, October 1998.

Update on the treatment of asthma in older patients. American Society of Consultant Pharmacists Meeting, Philadelphia, December 1997.

25

Evaluating access to pharmaceutical care by the elderly. Plenary speaker for the program The Challenges of Medication Management sponsored by the Wayne State University Institute of Gerontology, November, 1997.

Quality of life outcomes in pediatric pulmonary disease. Strategies for success in pediatric nursing, Sinclair Center, Dayton, Ohio, September 1997.

Quality of life outcomes in cystic fibrosis. The Children’s Medical Center, Pediatric Pulmonary Medicine, Dayton, Ohio, September 1997.

Providing pharmaceutical care: Variables associated with nonadherence. Stephen Wilson Seminar, Wayne State University College of Pharmacy, April, 1997.

Update on asthma and COPD in the elderly. Geriatric Consultant Resources, Consultant Pharmacists, Phoenix, Arizona, January, 1997.

Counseling the patient with asthma. Meijer Pharmacists, Lansing, Michigan, December 1996.

Evaluation of Quality of Life in Ambulatory Patients. The Great Lakes Regional Psychopharmacy Update 1996, June, 1996.

Update on Antihypertensive Therapy. Jackson Area Pharmacist Association, Jackson, Michigan, December 1995.

Update on Benign Prostatic Hyperplasia. Southeastern Michigan Society of Hospital Pharmacists, Southfield, MI, October 1995.

Update on Antihypertensive Therapy. Federal Pharmacists Association, Michigan. Livonia, MI, September 1995.

Pharmacologic assessment of the chronically ill elderly patient. Madonna University College of Nursing, Livonia, March 1995

Pharmacotherapy of benign prostatic hyperplasia. Veterans Administration Hospital, Allen Park, MI, February 1995

Pharmacotherapy and the Older Patient. Saginaw Area Pharmacists Association, Midland, MI, January 1995.

Medication related problems and the elderly. Michigan Nurses Association, Madonna University, Livonia, MI, November 1994.

Polypharmacy and the elderly. Implications for prescribers. St. Mary Hospital CME lecture, Livonia, MI, November 1994.

Management of the anticoagulated patient. Conducting DUE in the ambulatory clinic. Dearborn Inn, Dearborn, MI, November 1994.

26

Health care access issues for the elderly. Plenary speaker for the Wayne State University Institute of Gerontology Annual Seminar on Health Care Issues for the Elderly. May, 1994.

Counseling patients with special needs. Stephen Wilson Seminar, April 1994,Wayne State University, College of Pharmacy/Allied Health Professions, Detroit, MI.

OBRA 90 Patient Counseling Workshop and Lecture. Wayne County Pharmacist Association, Holiday Inn Dearborn, October 1993

Preceptor training program. OBRA 90 Patient counseling workshop facilitator, Ponchetrain Hotel, Department of Pharmacy Practice, WSU, September 1993

Update on nonsteroidal anti-inflammatory agents. MPA Interim Meeting, Dearborn, MI. February 1993

Refresher course in patient counseling. MPA Interim Meeting, Dearborn, MI. February 1993

Medication use and the elderly (MEPS program). MPA Annual Meeting, August 1992.

AIDS related drug therapy and the nursing home patient. Broadstreet Nursing Center Nursing/Physician CE Lecture, August 1992.

Quality of life issues for the pharmacist. MPA Interim Meeting, Dearborn, MI. February 1992

Nonsteroidal Anti-inflammatory agents - a review. Pharmacist CE lecture, Detroit Receiving Hospital, Detroit, MI, May 1991

Strategies for enhancing patient adherence. MPA Interim Meeting, Dearborn, MI. February 1991

An overview of antimicrobial therapy, Pharmacy CE, St. Mary Hospital, Livonia, MI, November 1989

Vancomycin pharmacokinetics and dosing, Pharmacy CE, St. Mary Hospital, Livonia, MI, September 1989

Antibiotic drug interactions, Physician CME, St. Mary Hospital, Livonia, MI, February 1989

Pharmacokinetic concepts and aminoglycoside dosing, Pharmacy CE, St. Mary Hospital, Livonia, MI, October 1988

Glaucoma - An overview of the disease and it's treatment, MPA 1984 Interim Meeting, Dearborn, MI, February 1984.

Phenytoin pharmacokinetics in the renal failure patient , Pharmacy CE, Detroit Receiving Hospital, Detroit, MI, November 1983.

Current Concepts in the treatment of urinary tract infections, Family Practice Grand Rounds, Department of Family Practice, WSU School of Medicine, Detroit, MI, August 1983.

27

Tardive dyskinesia; Case presentation, Pharmacy Grand Round, Harper Hospital, Detroit, MI, July 1983.

Auranofin - A new chrysotherapeutic agent, MPA 1983 Interim Meeting, Dearborn, MI, February 1983.

SERVICE

1. Professionally Related Service

State of Michigan Community Health, Developmental Disabilities Division, Dual Diagnosis guideline committee, 2012.

NIH/SBIR Special Emphasis Panel, Behavioral Health, 2011-2013, Grant Reviewer

Grant reviewer, American Heart Association Midwest Region, Fall 2009.

AHCPR Collateral Reviewer, Small Project Grants, October 1999.

Department of Defense, Congressional Interest Research on Health-related Topics Peer Review Panel, American Institute of Biological Sciences. Two proposals reviewed, 2/2000 and 3/2000.

Blue Cross/ Blue Shield of Michigan Pharmacy and Therapeutics Committee. (1999 to 2004)

State of Michigan Medicaid Program - Drug Utilization Review Board of Directors and Ann Arbor area drug utilization review committee - (1993 - 1997)

Michigan Pharmacists Association/MSHP Invitational Conference on Implementing Pharmaceutical Care, participant, March 1994, Lansing, MI.

Participant at the Michigan Society of Hospital Pharmacist Michigan Hilton Head Clinical Planning Conference, February 1989.

2. Positions Held/Committee Membership in Professional Associations

American Association of Colleges of Pharmacy (AACP), Pharmacy Practice Section, Nominations Committee member 1993-94; Membership and Resolutions Committee member 1994-95, Chairman 1995-96; Membership Committee member 2000-01.

American College of Clinical Pharmacy (ACCP), Constitution and Bylaws Committee member, 1994-95; Clinical Practice Affairs Committee member 1995-96; Educational Affairs Committee member 1999; Ambulatory Care PRN member 1992 to 2001; Ambulatory Care PRN membership chairman, 1992 – 1996.

Southeast Michigan Society of Hospital Pharmacists Committees

Program Committee - 1995, 1996

28

Banquet Committee - 1989, 1990Awards Committee - 1986, 1987

3. Professional Consultation

Nursing Home Consultant, Oakwood Hospital and TeleRex Pharmacy 1990 - 1994. Consulted with between 3 and 6 long-term care facilities in the Detroit Metropolitan area. Provided chart review, staff development, and pharmacokinetic dosing services. Acted as representative of the pharmacy at quality assurance meetings.

Cardiovascular Risk Assessment and Intervention at the Worksite. Protocol development. Bristol-Myers Squibb, November 1998.

4. Journal/Editorial Activity

Past Editorial Board Chairman, Health-related Quality of Life Section, Annals of Pharmacotherapy

Editorial Board, Current Medical Research and Opinion Editorial Board, Journal of Pharmacy Benefits

Reviewer for Pharmacotherapy Reviewer for Annals of Pharmacotherapy Reviewer for Clinical Therapeutics Reviewer for Value in Health Reviewer for Current Medical Research and Opinion Reviewer for Pharmacoeconomics Reviewer for Journal of Pharmacy Benefits Reviewer for American Journal of Managed Care Reviewer for Journal of Managed Care Pharmacy

Reviewer for American Pharmaceutical Association Disease-specific Pharmaceutical Care Protocols - Hypertension, February 1995 and its update 1998; Hyperlipidemia, March, 1996 and update 1998.

Advisory Board Chairman for American Pharmaceutical Association Publication “Teczem” 1997.

5. University of Michigan Service

University Faculty Senate, College of Pharmacy representative 1998 to 2002.

Member of the University of Michigan Health System Medical Guidelines working groups for Hypertension, Asthma, and Allergic Rhinitis, 1995 to 2000.

Member of the University of Michigan, Michigan Healthy Community Initiative Task Force, 2005.

College of Pharmacy Executive Committee, 2003 to 2006.

College of Pharmacy Curriculum Committee Chairman, 2005 to 2008, member 2005 to 2012.

29

College of Pharmacy Experiential Committee member, 2002 to 2005.

College of Pharmacy Mentor for Junior Faculty, 2005 to 2007.

College of Pharmacy Honor Council – chair, 2010 to present

University of Michigan MHealthy Committee, 2010-2012

University of Michigan Pharmacy Benefits Oversight Committee, member, 2010-present

College of Pharmacy Promotion and Tenure Committee Chairman, Suzan Kucukarslan, 2011.

College of Pharmacy Educational Outcomes Assessment Committee member, 2012 to present

6. Public education activities

Medication Brown Bag. St. Aidan Catholic Church, May 2008.

Pharmacy issues. University of Michigan Cardiology Implanted Cardiac-Defibrillator Support Group, March, 2005

Caregivers and Medication Issues. University of Michigan Turner Geriatric Center Social Work Department, Outreach Program. November 2004.

Pharmacy issues. University of Michigan Cardiology Implanted Cardiac-Defibrillator Support Group, June, 2003

Herbal medicines. University of Michigan Cardiology Implanted Cardiac-Defibrillator Support Group, April, 2003.

Heart Healthy Living. Medications used to lower cholesterol. Blue Care Network of Southeastern Michigan. Dearborn Hyatt, MI, July 1997.

Drug therapy for scleroderma. Southeast Michigan Chapter of Scleroderma support group. Providence Hospital, Southfield, November 1995.

Medication use and older people. Mature Mingles of West Bloomfield, MI. May 1995.

Generic drug use. Restoration Tower, Detroit, MI. November 1994.

Hannon House, Senior Service Center, Detroit, MI. Medication use lecture, March 1994.

Medication use in the elderly. Eldercare Summit 2. Virginia Park Williams Community Center, January 1993. Presentation on medication-use related problems of the elderly, given to local business and political leaders.

Assisting elderly home-bound with medication. Training session, Eldercare, St. Patrick's Senior Center, Detroit, November 1992.

30

Brown-bag days - several per year at senior centers around Detroit since 1991. Three presented during 1992. Two at the Williams Community Center (Virginia Park) where WSU pharmacy students assisted. One at St. Patrick's Senior Center, again with student assistance. 1993 November, St. Patrick’s senior center. Another student assisted Brown Bag was presented in December, 1993 at the Latino Family Center, Jefferson Ave, Detroit, MI; Restoration Tower brown bag October 1994.

Health-O-Rama participant - 1988 through 1991, 1994.

Assisting elderly home-bound with medication. Training session, Eldercare, St. Patrick's Senior Center, Detroit, November 1993.

Quality of life and high blood pressure therapy. Article in Pressure Pointers, publication written for the public and distributed throughout Michigan, Coalition for Cardiovascular Health. January 1992.

Drug therapy for scleroderma. Southeast Michigan Chapter of Scleroderma support group. Wm. Beaumont Hospital, November 1991.

Drug therapy for the elderly. Question and answer session, MEPPS program. Michigan Fairgrounds, June 1991.

Nonsteroidal anti-inflammatory agents. Public education commercial, FDA. July 1991.

Guest lecturer, Schoolcraft College, Medications and You, College of Lifelong Learning. Livonia, MI, June 1990 and again in August 1993.

Guest on Retirement Roads, a Livonia Cable Television program, discussed medication usage for the retired person. May 1990.

Over-the-Counter Medications, Heritage Hospital "55 and Alive" seminar, Presidential Motor Inn, Southgate, MI, October, 1988.

Updated 5 2013